A
A

Financials • Alpha Cognition

ACOG

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

12/2023
1 financial
12/2023
Year
12/2023
0
-14
-14
L
-5
L
-0
-
-11
0
8
-11
L

To see all financials—including updated, you must be Premium.